theory clinical_65_4
imports Main

begin

typedecl entity
typedecl event

consts
  Akt :: "entity ⇒ bool"
  Activated :: "entity ⇒ bool"
  Mediate :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Include :: "event ⇒ entity ⇒ bool"
  CellularFunctions :: "entity"
  Proliferation :: "entity"
  Survival :: "entity"
  Alpelisib :: "entity ⇒ bool"
  KinaseInhibitor :: "entity ⇒ bool"
  BreastCancers :: "entity ⇒ bool"
  Treatment :: "event ⇒ bool"
  In :: "event ⇒ entity ⇒ bool"
  Mutations :: "entity ⇒ bool"
  PI3K_AKT_Pathway :: "entity ⇒ bool"
  Target :: "event ⇒ bool"
  Involved :: "event ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Activation :: "event ⇒ bool"
  Lead :: "event ⇒ bool"
  Result :: "event ⇒ entity ⇒ bool"
  UncontrolledProliferation :: "entity"
  Directly :: "event ⇒ bool"

(* Explanation 1: Fully activated Akt mediates numerous cellular functions, including proliferation and survival. *)
axiomatization where
  explanation_1: "∃x e. Akt x ∧ Activated x ∧ Mediate e ∧ Agent e x ∧ Patient e CellularFunctions ∧ Include e Proliferation ∧ Include e Survival"

(* Explanation 2: Alpelisib is a kinase inhibitor used in the treatment of certain breast cancers. *)
axiomatization where
  explanation_2: "∃x y z e. Alpelisib x ∧ KinaseInhibitor y ∧ BreastCancers z ∧ Treatment e ∧ Agent e x ∧ Patient e y ∧ In e z"

(* Explanation 3: Kinase inhibitors can target mutations in the PI3K/AKT pathway, which is involved in cellular proliferation and survival, by inhibiting its activation. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. KinaseInhibitor x ∧ Mutations y ∧ PI3K_AKT_Pathway z ∧ Target e1 ∧ Agent e1 x ∧ Patient e1 y ∧ In e1 z ∧ Involved e2 ∧ Agent e2 y ∧ Patient e2 Proliferation ∧ Patient e2 Survival ∧ Inhibit e2 ∧ Activation e2"

(* Explanation 4: Mutations in the PI3K/AKT pathway can lead to uncontrolled cellular proliferation and survival. *)
axiomatization where
  explanation_4: "∃x y e. Mutations x ∧ PI3K_AKT_Pathway y ∧ In e x ∧ Lead e ∧ Agent e x ∧ Result e UncontrolledProliferation ∧ Result e Survival"

(* Explanation 5: Targeting mutations in the PI3K/AKT pathway with kinase inhibitors can directly inhibit cellular proliferation and survival. *)
axiomatization where
  explanation_5: "∃x y z e. KinaseInhibitor x ∧ Mutations y ∧ PI3K_AKT_Pathway z ∧ Target e ∧ Agent e x ∧ Patient e y ∧ In e z ∧ Inhibit e ∧ Directly e ∧ Patient e Proliferation ∧ Patient e Survival"

theorem hypothesis:
  assumes asm: "KinaseInhibitor x ∧ Mutations y ∧ PI3K_AKT_Pathway z"
  (* Hypothesis: Using a kinase inhibitor may target mutations in the PI3K/AKT pathway and inhibit proliferation and survival. *)
  shows "∃x y z e1 e2. KinaseInhibitor x ∧ Mutations y ∧ PI3K_AKT_Pathway z ∧ Target e1 ∧ Agent e1 x ∧ Patient e1 y ∧ In e1 z ∧ Inhibit e2 ∧ Agent e2 x ∧ Patient e2 Proliferation ∧ Patient e2 Survival"
  using explanation_5 by blast
  

end
